US approves emergency use of Pfizer-BioNTech vaccine

A nurse fills a syringe with a vaccine before administering an injection at a children's clinic in Kiev, Ukraine August 14, 2019. Picture taken August 14, 2019. REUTERS/Valentyn Ogirenko

Tista' taqra bil- Malti.

The US Food and Drug Administration has authorised the emergency distribution of the vaccine against coronavirus produced by Pfizer and BioNTech.

The agency was put under intense pressure from Trump’s administration to approve the vaccine without delay. According to the country’s media, the Head of the FDA, Stephen Hahn was told to either approve the vaccine or resign from his post. Hahn, on the other hand, denied these allegations.

US President Trump said that the first vaccinations will be rolled out in just 24 hours. So far, over 292,000 people succumbed due to the virus in the US.

The Heath and Human Services Secretary, Alex Azar, told reporters that he would be working, together with his department, to start off the programme for mass vaccination as of Monday or Tuesday.

This vaccine has so far been approved by the United Kingdom, Canada, Bahrain and Saudi Arabia.